Published in Vaccine Weekly, October 13th, 2004
The Canadian government has retained an option to purchase additional product from the company in the third and final year of the contract. The total value of the contract, including the third year option, could total approximately $30 million to ID Biomedical.
This contract was awarded by Public Works Canada on behalf of health ministries. The contract covers all Canadian provinces and territories, with the exception of Quebec, which already has its own meningitis C vaccine distribution program.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly